Shoreline Biosciences
Chad Viergever has a diverse background in bioengineering, research, and business. With experience in companies like Shoreline Biosciences, Anzu Partners, Genalyte, and Organovo, Chad has a strong foundation in corporate development, data analysis, and engineering. Their academic background includes a Bachelor's degree in Bioengineering from Stanford University and a Master of Business Administration from USC Marshall School of Business. Chad's work involves project management, data analysis, research assistance, and development of innovative products in the life sciences industry.
This person is not in any teams
Shoreline Biosciences
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.